The Psychosis Prodrome.
Psychotic disorders are devastating for individuals and their families as they involve the onset of symptoms and significant impairment during adolescence and young adulthood- two critical developmental periods when youth are only just starting to make a transition into independence. These disorders are highly prevalent (impacting between 1-2% of the population), and once diagnosed, involve a chronic course and challenging prognosis. However, an emerging research field suggests that we can now effectively identify those who are at imminently high-risk for psychosis, several years before onset (Figure 1).
High-risk syndromes are defined, in part, by attenuated positive symptoms (e.g., experiencing unusual thoughts, seeing brief shadows, hearing strange sounds). Individuals with these syndromes also show persistent difficulties with motor, perceptual, cognitive and emotive functioning. Cumulative, changes during the high-risk (or prodromal period) result in significant impact in social, academic and occupational functioning. Those who meet criteria for a high-risk syndrome have a chance of developing schizophrenia or an affective disorder with psychotic features within a two-year period. This serves as a foundation for a line of research that suggests that if we can identify high-risk adolescents and young adults and provide early intervention, the course of illness will be improved or perhaps prevented entirely.
How Can We Conceptualize the Prodrome?
In a neural diathesis-stress conceptualization of psychosis, individuals with a biological susceptibility (i.e., from inherited genes, mutations, and early prenatal teratogen/insult) often exhibit subtle signs of impairment from infancy and then carry these signs forward throughout childhood (e.g., delayed achievement of milestones such as walking/talking/toilet training; motor abnormalities; poor social skills and affective responsivity; cognitive deficits).
Much later, these vulnerabilities interact with the substantial environmental stressors and dramatic neural and endocrine maturational factors that occur during adolescence and early young-adulthood. During this time normative age related increases in sex hormones synergistically affect neurotransmitters and modulate gene expression. Further marked neural reorganization affects both connectivity and intercommunication between key brain structures and networks. It is also important to consider that the adolescent and young-adult time periods are characterized by a significant number of major life-stage decisions, as well as increases in every day stressors and responsibilities. Each of these social requirements involves making adult decisions without the benefit of a fully developed adult brain (e.g., limiting impulsive thinking and promoting efficient thinking). This can place additional burden on a progressively compromised system (indeed, one common experience is feeling more "thrown-off" by every day stressors). Finally, individuals in these stages are often exposed to additional environmental stresssors including substance abuse. Together, the early vulnerability interacts with adolescent and young-adult developmental factors as well as social and environmental stressors, contributing to emerging subtle attenuated psychotic symptoms. Some common symptoms include: finding a greater degree of meaning in everyday coincidences (aberrant salience), seeing shadows out of the corner of one’s eye, mild grandiosity, feeling vaguely suspicious of friends and family and experiencing increasing difficulty in getting one’s point across. In addition to these symptoms, adolescents and young adults in the prodrome often report negative symptoms (e.g., feeling low motivation, not enjoying things that were previously held to be pleasurable, feeling emotionally disconnected from the self or others), as well as difficulties with cognition (this can present as difficulty concentrating and increasing difficulty in school or at work) and emotional processing (this can present as exhibiting increasing difficult with processing and interacting with social situations). In turn, these emerging symptoms lead to increased stress, which may tax progressively compromised neural and hormonal systems. Indeed, because stressors influence hormones, and because of the important role that hormones (including stress hormones) play in regulating genes responsible for guiding brain development, the noted difficulties and environmental stressors can impair neural development, and consequently, contribute to further vulnerability. This may drive a cascade which eventually drives the onset of formal psychosis (e.g., schizophrenia, bipolar disorder with psychotic features, depression with psychotic features).
Why Does Development Matter?
Although serious mental illness can occur during a number of developmental periods, a majority of cases first develop at the end of adolescence and beginning of young-adulthood. As a result, it has become increasingly clear that developmental factors play an important pathogenic role. As seen in Figure 3, significant brain reorganization during adolescence and young adulthood overlaps with the emergence of symptoms. At the same time, the hormone system is highly active, regulating puberty by governing genes that modulate synaptic pruning and white-matter development. Both developmental systems are highly sensitive to environmental and social factors as well. Because of the emphasis on development in understanding factors in the high-risk period, we also focus each of our research questions within this context. With this in mind, the lab is dedicated to longitudinal research, and we employee a range of experimental paradigms and methodologies to assess the same individuals at different developmental time points. We are particularly interested in how factors contribute to an early vulnerability, and then, how environmental factors occurring during adolescence and young adulthood as well as brain and hormone development in this period unmasks this vulnerability, leading to emerging symptoms and other characteristics that impair quality of life and contribute to disability in these individuals.
What are the Priorities for Research in this Area?
The available research has consistently shown that roughly 10-35% of adolescents and young adults exhibiting a prodromal or high-risk syndrome (i.e., based on the course, frequency, and severity of a combination of the symptoms and characteristics noted above) will convert to a psychotic disorder within a two-year period (Figure 4).
A growing body of evidence also suggests that early intervention may be helpful for those at risk for psychopathology. Specifically, forming relationships with treatment providers prior to serious illness, adopting strategies prior to when severe and acute symptoms can interfere with the acquisition and assimilation of psychotherapy skills (e.g., stress management), engaging family members in both reducing the stressful environment and helping to monitor the subtle changing symptoms, and/or beginning treatment can ameliorate course of illness, and may help to delay or even prevent onset of a psychotic disorder.
Unfortunately, although we know that approximately 1/3rd of high-risk individuals will convert to an Axis I psychotic disorder in a short period of time, we are not certain whom among the at-risk group is most likely to fall into this category. As blanket treatment for all high-risk individuals is not a feasible method for intervention (due to costs of psycho-social and pharmacological interventions as well as ethical concerns relating to medication side-effects), identifying those individuals at highest risk for this conversion is a urgent and important research priority. Further, developing new effective targeted treatments (capable of treating symptoms and characteristics that are impairing, but have yet benefited from effective interventions) is critical. Our belief is that we can use data from longitudinal and experimental investigations to inform early identification and intervention.
What is ADAPT doing about it?
This period of transition during adolescence and young adulthood (i.e., the prodromal or high-risk period), immediately before the formal onset of psychosis, holds the unique potential to both inform etiological conceptualizations of psychotic disorders, and serve as a viable point for early intervention and/or prevention.
To date, the ADAPT lab has specialized in several distinct, but mechanistically related susceptibility markers, behaviors, and symptoms that reflect 1) disordered communication between the subcortical structures that govern basic human function and the frontal regions that underlie higher order functions and 2) abnormalities in medial temporal brain structures and function. We have focused on these phenomena because they appear to interact with developmental and genetic factors, share related neurological underpinnings that also characterize psychosis, and are quantifiable, potentially enabling a system of early identification and intervention.
Details from each of these studies can be found on the lab publication page.
Basal Ganglia and Cerebellar Circuits
Psychotic disorders are characterized by distinct domains of symptoms as well as emotional, nonverbal, and cognitive deficits drawing upon a host of disparate mechanisms and structures. Our first line of research tests the idea that the basal-ganglia circuits, which are responsible for dynamic communication between the subcortical structures that govern basic functions and the frontal regions that underlie higher order functions (e.g., cognition, perception, motivation/reward, emotion), are a good target for improving our understanding why such a wide variety of functions are affected in psychosis (Figure 5; from Obeso et al.). Current thought holds that markers of dysfunction in one structure or circuit will also be indicative of dysfunction in other loops (as the circuits are governed by the same neurotransmitter systems). Within this context we have been particularly focused on domains of motor behavior (e.g., gesture) and types of movement dysfunction (dyskinesia, soft signs, dyspraxia), as these characteristics reflect basal-ganglia circuit dysfunction as well as dysfunctional integration between the basal ganglia circuits and other relevant domains. Figure 6 illustrates results one of our preliminary studies.
Further, as these circuits are influenced by inflammation, there is significant promise for understanding this work in broader conceptual frameworks. In addition, approaches such as transcranial direction current stimulation (tDCS) hold significant promise for elucidating specific aspects of these circuits and employing novel interventions. In following this line of inquiry, we have also focused on how basal ganglia circuit pathology affects characteristic domains of psychosis including emotion, perception, cognition, and reward. In addition, we have expanded the study in this area to the cerebellar circuits- another critical system that is affected in schizophrenia and believed to govern coordination and balance as well as synchronize cognitive functions (see Figure 7). Our preliminary work in this area suggests that the cerebellar system may account for a unique category of symptoms and cognitive deficits. Our current efforts focus on integrating the two systems to provide a better understanding of unique and overlapping contributions to symptom domains and areas of cognitive function; these efforts hold potential for supplementing traditional observer symptom-based classification system with a biologically based approach (more akin to diagnosis in medicine).
There is a significant translational component to this research program that applies specifically to early identification. As noted, approximately 10-33% of high-risk individuals go on to develop psychosis, but because we don’t know which of the initial cases (who exhibit similar clinical presentations) will be in this group, blanket intervention is not feasible (due to costs and side effects associated with many of the currently available treatments). Our work with biomarker development has significantly helped to improve efforts to identify which individuals in this initial group are most likely to develop psychosis.
We have also been working with researchers to develop tools that can be used to disseminate these findings to clinical settings, and be applied to improve treatment decisions. For example, we are working with a team developing a program for analyzing pen dysfluencies in handwriting (possible to be assessed on any tablet computer), and our preliminary results suggest by focusing on specific markers, we can accurately detect the same movement abnormalities that previously would have required a highly specialized neurological training background (Figure 8). With regard to the cerebellar circuits, we have recently reported findings that suggest that deficits determined by a brief neurological battery can significantly predict abnormalities in cerebellar-thalamic white matter tracts (Figure 9) that are tied to progressively worse symptoms. As a result, clinicians who do not have access to neuroimaging facilities may also be able identify patients in greatest need of intervention. We are also launching new treatment development study, evaluating if cerebellar stimulation is effective in improving verbal working memory deficits in early psychosis. In this context, our lab will be one of the first to utilize tDCS in conjunction with fMRI (participants will receive sham or active stimulation immediately proceeding the scan session), and this approach will provide a significantly improved understanding of how cerebellar-thalamic circuit dysfunction contributes to verbal working memory deficits in psychosis, and further, how brain stimulation modulates activity in this vital circuit. This will help to lay the foundation for innovative new treatments targeting areas that significantly contribute to disability, such as cognition.
Hippocampal Function, Stress, and Exercise Interventions
The hippocampal system, responsible for moderating biological stress reactivity as well as integral cognitive functions, is highly implicated in psychosis as it may serve as an interaction point between the environment and underlying biological susceptibility. Our second line of research focuses on hippocampal development (longitudinal changes in shape, structure/connective tracts, and function) (Figure 10), interactions with psychosocial stress and related hormones such as cortisol (using paradigms involving life-events and expressed emotion/family environment, and Social Stress Tests) and causal factors underlying system vulnerability (e.g., obstetric complications, inflammation). For example, in one longitudinal investigation we found that hippocampapal shape anomalies predict a poorer course of illness for those at psychosis risk. Recently, we have also observed that family environment influences resting levels of stress hormones, and that self-concept may moderate this relationship.
There are several translational components to this work that we are particularly enthusiastic about. It is important to consider that while several of the available treatments for individuals at high-risk for psychosis have been found to show some promise in terms of improving prognosis and cognitive function, including cognitive training (which acts upon hippocampal mediated synaptic plasticity). To this end, we have been particularly interested in translating the findings from our longitudinal naturalistic studies into a viable treatment for high-risk youth. Most recently, we have begun to develop a related line of research examining how hippocampal development is effected by physical activity in at-risk youth. Because the hippocampus is a critical structure for de-escalating the stress response, has been found to develop abnormally in high-risk adolescents , and is believed to contribute to cognitive dysfunction, this structure is a key treatment target (Figure 11). If we can harness aerobic exercise, an activity that is widely available, inexpensive, and accompanies few side-effects, this could have a significant public health impact.
An emerging literature suggests that regular aerobic activity can stimulate hippocampal neurogenesis (Figure 12), and we have begun to investigate the potential for an exercise intervention for high-risk youth. In an initial study, we found that high-risk youth engaged in significantly more sedentary but less aerobic activity than controls (assessed with actigraphy over a 5-day period) and that inactivity was associated with smaller medial temporal structures in this group. Following this investigation, we collaborated with Angela Bryan (Co-PI) to propose a related intervention and the study was funded through an innovative translational award that combines a phase 1 stage(to test the underlying mechanism and fine-tune the treatment parameters) and a phase 2 randomized controlled trial (RCT). In this ongoing study (currently in Year 2), we are working to determine if prescribed exercise (monitored exercise for 3 times a week for 12 weeks) will lead to better fitness (V02 Max), hippocampal cell growth, improved episodic memory, and reduced symptoms in this critical population.
We are also preparing to examine if brain derived neurotrophic factor (BDNF) RNA expression changes as a function of aerobic exercise, and if it in turn, mediates the beneficial relationships between exercise and the brain. As exercise may indeed influence factors such as synaptic plasticity, this work has significant potential for future trials conducted in conjunction with treatments involving cognitive training (Figure 13).
The ADAPT lab specializes in focusing on brain, endocrine, and motor changes during adolescence and young adulthood with the goals of:
- understanding the role of development in emerging psychopathology
- identifying biosignatures
- informing innovative treatments
Our guiding mission is to translate knowledge from basic science approaches to practical and widely disseminable biomarkers and targeted interventions. To accomplish these goals we utilize naturalistic (longitudinal) and experimental behavioral paradigms, multi-modal neuroimaging, hormone analysis, instrumental motor assessments and exercise physiology.
In addition to our own primary areas of expertise, the ADAPT lab also works actively with several collaborators to employ innovative methodologies for examining our guiding research questions (involving frontal subcortical circuits, hippocampal function, and neural/endocrine development) as well as mediating factors (e.g., substance use and inflammation). Collectively, we employ advanced multi-modal imaging (Figure 14), instrumental and VR assessments of movement and cognitive behavior, automated nonverbal behavior and emotive evaluation, hormone analysis (blood, saliva, and hair analysis), transcranial direct current stimulation (tDCS) (see Figure 15), auditory analysis, experienced sampling/actigraphy, stress sensitivity, aerobic fitness assessment (V02 Max), computerized linguistic and semantic analysis, eye tracking (employing paradigms at both 150 and 1000 hz paradigms), electroencephalography (EEG), electromyography (EMG) (Figure 16), and inflammatory marker, DNA and RNA analysis. Students interested in working with ADAPT will have the option to work with any of our primary or collaborator-guided methodologies. Participants who prefer to not participate in a particular component are still largely welcome to participate in those areas that they do feel comfortable with.
In addition to the two primarily research lines noted above, we are also interested in several other side studies involving graduate student projects that may eventually develop into more formalized programs and larger grant applications. These fall under the umbrella of the lab mission (promoting etiological understanding and identifying vulnerability makers of risk for developing psychotic disorders), but also reflect unique student interests as well (that they can carry on to their own labs in the future). To date these have involved a series of projects designed to study sleep dysfunction, Internet behaviors, and assessment/instrument development (we are focusing on developing a negative symptom instrument for high-risk youth). The ADAPT lab is also dedicated to improving classification and assessment. To this end we have authored several critical commentaries, reviews, and communications pertaining to the classification of movement abnormalities in psychiatric illness. In addition, the lab works to write peer-reviewed commentaries of assessment issues that are informed by experiences with at-risk youth. We also have recently published a new scale, designed to evaluate negative symptoms in the prodromal stage. We are also passionate about mental health advocacy and public policy. Most recently, we collaborated with Elyn Saks (Professor of Law at USC and prestigious mental health advocate) to evaluate ethical and legal dilemmas inherent in disclosing an attenuated psychosis syndrome diagnosis to patients and families.